#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Brain abscess Anti-myelin-associated glycoprotein associated polyneuropathy Ovarian cancer stage III Univentricular heart Squamous cell carcinoma of the cervix Neurofibromatosis Myasthenia gravis Acute graft versus host disease in skin Intracranial calcification Narcolepsy Epstein-Barr virus infection Glomerulonephritis minimal lesion Waldenstrom's macroglobulinaemia Niemann-Pick disease Warm autoimmune haemolytic anaemia More trials…

    Learn about Rare Diseases

    Hereditary ataxia – Treatment Bronchopulmonary dysplasia Toxic epidermal necrolysis – Trials in Disease Mucous membrane pemphigoid – Treatment Factor VIII deficiency Pleural mesothelioma malignant – Life with Disease Langerhans cell sarcoma – Trials in Disease Fabry’s disease – Basic Information Retinitis pigmentosa – Treatment Angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Menotrophin Obefazimod Edg-5506 Inclisiran Sodium Piflufolastat (18F) TAZAROTENE Atidarsagene Autotemcel Magnesium Stearate SEVABERTINIB Ziprasidone Alprazolam Opevesostat Tosilate Tenofovir Alafenamide Epoetin Alfa Dacarbazine Umeclidinium Bromide Gandotinib Regn7257 Tecovirimat Calcitriol More therapies…

    Learn about Your Condition

    Mesothelioma Nodal osteoarthritis Critical illness Acquired ATTR amyloidosis Endocarditis enterococcal Myofascial pain syndrome Renal failure Anal squamous cell carcinoma Dyspepsia Intermittent claudication Small intestine adenocarcinoma Urticaria chronic Incisional hernia Neuropathic arthropathy Marfan's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Selinexor and Gemcitabine for Patients with Advanced Soft-Tissue Sarcoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Selinexor
    • Gemcitabine
    Spain

  • Study on Etoposide for Patients with Severe Hemophagocytic Lymphohistiocytosis in Intensive Care

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Etoposide
    France

  • Study of FG001 for Detecting Meningioma or Low-Grade Glioma in Patients Undergoing Neurosurgery

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • FG001
    Denmark

  • Study on Niraparib for Patients with Advanced Urothelial Cancer After Initial Platinum Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Genitourinary tract neoplasm
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    Italy

  • Study on the Safety and Effectiveness of Fludarabine and Treosulfan for Stem Cell Transplant in Acute Myeloid Leukemia Patients Aged 40 to 65

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    • Treosulfan
    • Methotrexate Sodium
    Italy

  • Study on the Effects of VRDN-003 for Patients with Active Thyroid Eye Disease

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • VRDN-003
    Germany Hungary The Netherlands Poland Spain
Previous Page
1 … 839 840 841 842 843 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!